Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Liz KaneImpactful Strategy
Paul TheisenPatient Acquisition
Pat PurcellMeeting Engagement
Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Cosentyx® is the first and only IL-17A inhibitor to show sustained improvements in signs ...
GENFIT: New Preclinical Data Shows Elafibranor Inhibits Development of NAFLD/NASH-Related Cancer Elafibranor administration prevented ...
NEWTOWN, Pa., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email